Effects of GABA-B receptor positive modulator on ketamine-induced psychosis-relevant behaviors and hippocampal electrical activity in freely moving rats.
A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.
Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disorders.
Seroepidemiological Study of Toxoplasma gondii Infection among Psychiatric Patients in Mashhad, Northeast of Iran.
Neurological soft signs precede the onset of schizophrenia: a study of individuals with schizotypy, ultra-high-risk individuals, and first-onset schizophrenia.
A comparative meta-analysis of neurocognition in first-degree relatives of patients with schizophrenia and bipolar disorder.
Measuring alterations in oscillatory brain networks in schizophrenia with resting-state MEG: State-of-the-art and methodological challenges.
Adolescent stress leads to glutamatergic disturbance through dopaminergic abnormalities in the prefrontal cortex of genetically vulnerable mice.
The impact of cognitive insight, self-stigma, and medication compliance on the quality of life in patients with schizophrenia.
Diagnostic validity of ICD-10 acute and transient psychotic disorders and DSM-5 brief psychotic disorder.
Patient Satisfaction and Quality of Life in People with Schizophrenia-Spectrum Disorders in a Rural Area.
Characterizing the inpatient care of young adults experiencing early psychosis: A medical record review.
Schizophrenia dissection by five anxiety and depressive subtype comorbidities: Clinical implications and evolutionary perspective.
Attentional avoidance increases voice hearing in an analogue task in people with psychosis: An experimental study.
Novel 3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands With Antipsychotic-like, Mood-Modulating And Procognitive Activity.
Explanatory models and distress in primary caregivers of patients with acute psychotic presentations: A study from South India.
Adherence to Antipsychotic Therapy: Association With Hospitalization and Medicare Spending Among Part D Enrollees With Schizophrenia.
Dissociable auditory mismatch response and connectivity patterns in adolescents with schizophrenia and adolescents with bipolar disorder with psychosis: A magnetoencephalography study.
Psychometric properties of the short Warwick Edinburgh mental well-being scale (SWEMWBS) in service users with schizophrenia, depression and anxiety spectrum disorders.
[The most cited themes in the research in the field of Mental Health: analyses of six international nursing and medical journals].
Efficacy Towards Negative Symptoms and Safety of Repetitive Transcranial Magnetic Stimulation Treatment for Patients with Schizophrenia: A Systematic Review.
Efficacy and Metabolic Influence on Blood-Glucose and Serum Lipid of Ziprasidone in the Treatment of Elderly Patients with First-Episode Schizophrenia.
The Effects of Prenatal Iron Deficiency and Risperidone Treatment on the Rat Frontal Cortex: A Proteomic Analysis.
The Binding Effect of Proteins on Medications and Its Impact on Electrochemical Sensing: Antipsychotic Clozapine as a Case Study.
Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders.
Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure.
Ameliorative effect of chlorpromazine hydrochloride on visceral hypersensitivity in rats: possible involvement of 5-HT2A receptor.
A school-based epidemiological field survey: difficulties in collecting psychiatric outcome data in a middle-income country.
Associations of psychotic-like or manic-like experiences with later psychiatric disorders: An 11-year follow-up study of middle-aged adults.
In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
Caregiver burden in schizophrenia following paliperidone palmitate long acting injectables treatment: pooled analysis of two double-blind randomized phase three studies.
The mediator effect of personality traits on the relationship between childhood abuse and depressive symptoms in schizophrenia.
Oculomotricity and Neurological Soft Signs: Can we refine the endophenotype? A study in subjects belonging to the spectrum of schizophrenia.
Anticholinergic use trends in 14,013 patients with schizophrenia from three national surveys on the use of psychotropic medications in China (2002-2012).
Perceived expressed emotions in relatives of patients with severe mental illness: A comparative study.
Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.
Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study.
Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
Developing a metformin prescribing tool for use in adults with mental illness to reduce medication-related weight gain and cardiovascular risk.
Prevalence, characteristics and management of headache experienced by people with schizophrenia and schizoaffective disorder: a cross sectional cohort study.
Glutamate/GABA+ ratio is associated with the psychosocial domain of autistic and schizotypal traits.
Prenatal developmental origins of behavior and mental health: the influence of maternal stress in pregnancy.
Stress sensitivity as a putative mechanism linking childhood trauma and psychopathology in youth's daily life.
Dimensional Traits of Schizotypy Associated With Glycine Receptor GLRA1 Polymorphism: An Exploratory Candidate-Gene Association Study.
Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine.
Beyond diagnosis: the Core Sets for persons with schizophrenia based on the World Health Organization's International Classification of Functioning, Disability, and Health.
Physiological and pharmacological properties of inhibitory postsynaptic currents mediated by α5β1γ2, α5β2γ2 and α5β3γ2 GABAA receptors.
The central serotonin2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research.
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
The chronic sorrow experiences of caregivers of clients with schizophrenia in Taiwan: A phenomenological study.
Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis.
Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features.
Directly observed therapy for clozapine with concomitant methadone prescription: a method for improving adherence and outcome.
Association between the scores of the Japanese version of the brief assessment of cognition in schizophrenia and whole-brain structure in patients with chronic schizophrenia: a voxel-based morphometry and diffusion tensor imaging study.